SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-004448
Filing Date
2024-04-01
Accepted
2024-04-01 08:25:16
Documents
6
Period of Report
2024-05-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20240501xdef14a.htm DEF 14A 1125509
2 GRAPHIC tmb-20240501xdef14a_a001.jpg GRAPHIC 3755
3 GRAPHIC tmb-20240501xdef14a_a005.jpg GRAPHIC 35239
4 GRAPHIC tmb-20240501xdef14a_a006.jpg GRAPHIC 33223
5 GRAPHIC tmb-20240501xdef14a_bg001.jpg GRAPHIC 128951
6 GRAPHIC tmb-20240501xdef14a_bg002.jpg GRAPHIC 103988
  Complete submission text file 0001558370-24-004448.txt   1547509
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36177 | Film No.: 24805700
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)